Soon after graduation, Tony Tam (PhD ’18) advances drug development and formulation at Merck.
Research
Patients Taking Opioids Produce Antibodies That May Hinder Anti-Opioid Vaccine
By Eric Hamilton This article originally appeared on UW–Madison’s news page. University of Wisconsin–Madison scientists have discovered that a majority of people they tested who were taking opioid painkillers for chronic back pain produced antibodies against …
2019 National Pharmacist Workforce Study Reveals Positive Trends
A nationwide study into the pharmacist workforce finds that clinical services and ambulatory care are growing as the workforce becomes more diverse.
Antibodies to Boost Treatments for Depression
With NIH BRAINS award, Assistant Professor Cody Wenthur is using a vaccine approach to develop safer and more effective antidepressants from ketamine.
Science to Benefit the Greater Good
From biotech to the ongoing COVID-19 response, alum Mark Rogge (BS ’82, MS ’84) is leading the charge.
Tracy Laabs Honored as 2020 PharmTox Alumnus of the Year
Alumna Tracy Laabs (BS ’01) has spent her career propelling neuroengineering and neurotechnology.
Blue Crabs, Adapted to Fluctuating Oxygen, Reveal Dynamic Neurochemical Responses to Hypoxia
Professor Lingjun Li’s mass spectrometry expertise enables large-scale discovery of low-abundance neuropeptides with potential applications in medical and environmental challenges.
The Opioid Conversation
School of Pharmacy team conducts statewide testing to facilitate patient education about opioid medications.
Pharmaceutical Sciences Student Awarded NIH Chemistry-Biology Interface Training Grant
Out of 34 competitive applications across the UW–Madison campus, Chelsi Almodóvar-Rivera was one of three students selected for the newest CBI program cohort.
Reducing Antibiotic Resistance in Nursing Homes
Newly published research explores the impact of antibiotic prescription reviews in nursing homes.